Long Term Progression-Free Survival in a Patient with Locally Advanced Prostate Cancer under Low Dose Intermittent Androgen Deprivation Therapy with Bicalutamide Only

Long Term Progression-Free Survival in a Patient with Locally Advanced Prostate Cancer under Low Dose Intermittent Androgen Deprivation Therapy with Bicalutamide Only

Androgen deprivation is a common treatment option in patients with locally advanced or metastatic prostate cancer. No case of long term treatment with an intermittent approach with only low dose bicalutamide (50 mg daily) has been described yet. We report a 60-year-old patient, initially presenting...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefan Latz, Christian Fisang, Wolfram Ebert, Stefan Orth, Dirk G. Engehausen, Stefan C. Müller, Ralf Anding
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Urology
Online Access:http://dx.doi.org/10.1155/2015/928787
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items